Martine A. Rothblatt, Director: United Therapeutics UTHR Sell · Filed 24/05/22

Trade details

Type: Insider sale
Amount: $657,709.84
Shares · price: 2,399 sh · $274.16 a share
Held after: 268 sh
Stock: United Therapeutics UTHR
Person: Martine A. RothblattDirector
Trade date: 24/05/20
Filed: 24/05/22
Days to filing: 2 days

Sold 90.0% of holdings

Share of holding sold: 90.0%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 24/04/20~24/06/19

Martine A. Rothblatt's recent trades

Martine A. RothblattChairperson & CEO
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 plan
United Therapeutics
UTHR
$220.2K
400 sh
$220.2K
Filed 10/01
Traded 09/30
Martine A. RothblattChairperson & CEO
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 plan
United Therapeutics
UTHR
$218.9K
400 sh
$218.9K
Filed 10/01
Traded 09/30
Martine A. RothblattChairperson & CEO
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 plan
United Therapeutics
UTHR
$153.5K
280 sh
$153.5K
Filed 10/01
Traded 09/30
Martine A. RothblattChairperson & CEO
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 plan
United Therapeutics
UTHR
$131.9K
240 sh
$131.9K
Filed 10/01
Traded 09/30
Martine A. RothblattChairperson & CEO
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 plan
United Therapeutics
UTHR
$114.8K
207 sh
$114.8K
Filed 10/01
Traded 09/30